Powerful Medical
3. November 2024
5 min to read

State-of-the-Art Review – From ST-Segment Elevation MI to Occlusion MI: The New Paradigm Shift in Acute Myocardial Infarction

Overview:

This state-of-the-art review explores the evolution of heart attack classification, challenging the limitations of the standard-of-care STEMI/NSTEMI framework. It advocates for a shift toward diagnosing heart attacks based on the presence of acute vessel occlusion rather than relying solely on standard ECG criteria. By redefining how myocardial infarctions are identified and managed, this approach has the potential to reduce misdiagnoses, optimize triage, and refine treatment prioritization in emergency cardiology.

Published In: Journal of the American College of Cardiology (JACC) – JACC Advances
Presented Date: November 03, 2024

Introduction

A generation ago thrombolytic therapy led to a paradigm shift in myocardial infarction (MI), from Q-wave/non-Q-wave to ST-segment elevation MI (STEMI) vs non-STEMI. Using STE on the electrocardiogram (ECG) as a surrogate marker for acute coronary occlusion (ACO) allowed for rapid diagnosis and treatment. But the vast research catalyzed by the STEMI paradigm has revealed increasing anomalies: 25% of “non-STEMI” have ACO with delayed reperfusion and higher mortality. Studying these limitations has given rise to the occlusion MI (OMI) paradigm, based on the presence or absence of ACO in the patient rather than STE on ECG. The OMI paradigm shift harnesses advanced ECG interpretation aided by artificial intelligence, complementary bedside echocardiography and advanced imaging, and clinical signs of refractory ischemia, and offers the next opportunity to transform emergency cardiology and improve patient care. This State-of-the-Art Review examines the paradigm shifts from Q wave to STEMI to OMI.

Highlights

  • The STEMI paradigm transformed emergency cardiology, but there is increasing recognition of its limitations.
  • STEMI criteria is a poor surrogate marker for acute coronary occlusion, leading to delayed reperfusion.
  • Evidence-based advances can identify OMI not meeting STEMI criteria, and false positive STEMI.
  • The OMI paradigm harnesses advanced ECG interpretation aided by artificial intelligence, echocardiography, and advanced imaging.

Authors: Jesse McLaren, José Nunes de Alencar, Emre K. Aslanger, H Pendell Meyers, and Stephen W. Smith

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

ECG Patterns of Occlusion Myocardial Infarction: a Narrative Review

This comprehensive review highlights the limitations of the traditional STEMI/NSTEMI classification for heart attacks and advocates for a more precise approach to diagnosis and patient triage. Instead of relying solely on standard ECG criteria, this method focuses on ECG patterns that more accurately reflect the severity of underlying coronary vessel disease. By identifying high-risk ECG changes beyond current STEMI guidelines, clinicians can detect heart attacks earlier, initiate treatment faster, and ultimately improve patient outcomes.

Artificial Intelligence–Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality: AI-ECG TIMI Study Design and Rationale

The AI-ECG TIMI study is a unique, multicenter registry currently enrolling patients to evaluate an AI-powered ECG model for detecting actively obstructed arteries in acute coronary syndrome (ACS). It is the first study to collect standard 12-lead ECGs precisely at the time of coronary angiography, providing novel insights into coronary occlusion and reperfusion. By identifying high-risk ECG patterns and assessing AI’s role in predicting intervention success, it paves the way for AI-driven precision cardiology in acute care.

Join 25,000 healthcare professionals who are already taking advantage of AI